Mirtazapine and Bupropion Combined Treatment in Treatment-resistant Depression
نویسنده
چکیده
Treatment-resistant depression is a difficult problem in clinical practice. Evidence for the efficacy of newer antidepressants, such as duloxetine and bupropion, is not yet well established. We present a case of treatmentresistant depression with full recovery where a combination of mirtazapine and bupropion was used after a failed response to combined mirtazapine and duloxetine treatment. [Tzu Chi Med J 2009;21(4):352–354] Article info Article history: Received: November 10, 2008 Revised: December 2, 2008 Accepted: December 8, 2008
منابع مشابه
Mirtazapine for treatment-resistant depression: a preliminary report.
OBJECTIVE To describe the effectiveness and tolerability of mirtazapine, a noradrenergic and specific serotonergic antidepressant, in the open-label treatment of patients with depression who were resistant to other antidepressant agents. METHODS The charts of 24 patients who met the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, (DSM-IV) criteria for major depressive d...
متن کاملPlatelet-Derived Growth Factor as an Antidepressant Treatment Selection Biomarker: Higher Levels Selectively Predict Better Outcomes with Bupropion-SSRI Combination
Background Platelet derived growth factor is integral to maintenance of blood brain barrier, increases in response to blood brain barrier disruption, and may reflect neuroinflammation. Based on previous reports of better outcomes with dopaminergic antidepressants in depressed patients with elevated inflammatory biomarkers, we hypothesize that elevated peripheral platelet derived growth factor l...
متن کاملInfluence of body mass index on the choice of therapy for depression and follow-up care
OBJECTIVE Overweight and obese patients commonly suffer from depression and choice of depression therapy may alter weight. We conducted a cohort study to investigate whether obesity is associated with treatment choices for depression; and whether obesity is associated with appropriate duration of depression treatment and receipt of follow-up visits. DESIGN AND METHODS Adults with a diagnosis ...
متن کاملDepression in Parkinson's disease: diagnosis and treatment.
The prevalence of non-motor symptoms in Parkinson's disease (PD) is high. Depression varies from 20 to 50% of the PD patients, and is associated with increasing disability. The key characteristics of depression are anhedonia and low mood. The recommended scales for screening purposes are: HAM-D, BDI, HADS, MADRS and GDS. As for measurement of severity: HAM-D, MADRS, BDI and SDS. In cases with m...
متن کاملEfficacy of SSRIs and newer antidepressants in severe depression: comparison with TCAs.
BACKGROUND The significant morbidity and mortality associated with severe depression and its psychotic or melancholic subtypes necessitate effective and well-tolerated therapy. This review evaluates antidepressant treatments for patients with severe depression. DATA SOURCES Comparative clinical trials conducted on patients with severe depression were found by an English-language MEDLINE searc...
متن کامل